Literature DB >> 30262125

Systematic review and meta-analysis of risk-reductive dental strategies for medication related osteonecrosis of the jaw among cancer patients: Approaches and strategies.

Rama Jayaraj1, Chellan Kumarasamy2, Suja Ramalingam3, Arikketh Devi4.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 30262125     DOI： 10.1016/j.oraloncology.2018.09.017

Source DB:  PubMed          Journal:  Oral Oncol        ISSN： 1368-8375            Impact factor:   5.337


× No keyword cloud information.
  12 in total

Review 1.  Prognostic Significance of FOXC1 in Various Cancers: A Systematic Review and Meta-Analysis.

Authors:  Nadana Sabapathi; Shanthi Sabarimurugan; Madhav Madurantakam Royam; Chellan Kumarasamy; Xingzhi Xu; Gaixia Xu; Rama Jayaraj
Journal:  Mol Diagn Ther       Date:  2019-12       Impact factor: 4.074

2.  Prognostic significance of blood inflammatory biomarkers NLR, PLR, and LMR in cancer-A protocol for systematic review and meta-analysis.

Authors:  Chellan Kumarasamy; Shanthi Sabarimurugan; Royam Madhav Madurantakam; Kartik Lakhotiya; Suja Samiappan; Siddhratha Baxi; Ramesh Nachimuthu; Kodiveri Muthukaliannan Gothandam; Rama Jayaraj
Journal:  Medicine (Baltimore)       Date:  2019-06       Impact factor: 1.817

3.  Meta-analysis of the prognostic role of HE4 expression in cancer patients: clinical insights into interpretation of clinical outcomes.

Authors:  Rama Jayaraj; Chellan Kumarasamy
Journal:  Cancer Manag Res       Date:  2019-02-21       Impact factor: 3.989

4.  Validation of miRNA prognostic significance in stage II colorectal cancer: A protocol for systematic review and meta-analysis of observational clinical studies.

Authors:  Shanthi Sabarimurugan; Chellan Kumarasamy; Madhav Madurantakam Royam; Karthik Lakhotiya; Gothandam Kodiveri Muthukaliannan; Suja Ramalingam; Rama Jayaraj
Journal:  Medicine (Baltimore)       Date:  2019-03       Impact factor: 1.889

5.  Comment on "Increased risk of second cancers at sites associated with HPV after a prior HPV-associated malignancy, a systematic review and meta-analysis".

Authors:  Rama Jayaraj; Chellan Kumarasamy
Journal:  Br J Cancer       Date:  2019-03-26       Impact factor: 7.640

6.  Diagnostic and prognostic role of HE4 expression in multiple carcinomas: A protocol for systematic review and meta-analysis.

Authors:  Chellan Kumarasamy; Madurantakam Royam Madhav; Shanthi Sabarimurugan; Kartik Lakhotiya; Venkatesh Pandey; T Priyadharshini; Siddhratha Baxi; K M Gothandam; Rama Jayaraj
Journal:  Medicine (Baltimore)       Date:  2019-07       Impact factor: 1.817

7.  Prognostic Value of miRNAs in Head and Neck Cancers: A Comprehensive Systematic and Meta-Analysis.

Authors:  Chellan Kumarasamy; Madurantakam Royam Madhav; Shanthi Sabarimurugan; Sunil Krishnan; Siddhartha Baxi; Ajay Gupta; K M Gothandam; Rama Jayaraj
Journal:  Cells       Date:  2019-07-25       Impact factor: 6.600

8.  The Significance of miRNAs as a Prognostic Biomarker for Survival Outcome in T Cell - Acute Lymphoblastic Leukemia Patients: A Systematic Review and Meta-Analysis.

Authors:  Shanthi Sabarimurugan; Chellan Kumarasamy; Madurantakam Royam Madhav; Suja Samiappan; Rama Jayaraj
Journal:  Cancer Manag Res       Date:  2020-02-05       Impact factor: 3.989

9.  Prognostic miRNA classifiers in t cell acute lymphoblastic leukemia: Study protocol for a systematic review and meta-analysis of observational clinical studies.

Authors:  Shanthi Sabarimurugan; Madhav Madurantakam Royam; Chellan Kumarasamy; Gothandam Kodiveri Muthukaliannan; Suja Samiappan; Rama Jayaraj
Journal:  Medicine (Baltimore)       Date:  2019-03       Impact factor: 1.889

10.  Clinical Theragnostic Potential of Diverse miRNA Expressions in Prostate Cancer: A Systematic Review and Meta-Analysis.

Authors:  Rama Jayaraj; Greg Raymond; Sunil Krishnan; Katherine S Tzou; Siddhartha Baxi; M Ravishankar Ram; Suresh Kumar Govind; Harish C Chandramoorthy; Faisal N Abu-Khzam; Peter Shaw
Journal:  Cancers (Basel)       Date:  2020-05-09       Impact factor: 6.639
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.